GSK Investigational Site

SanJuan, Puerto Rico 90660

0 studies enrolling now · 14 studies all time

What they study most

Alzheimer's Disease, Asthma, Epilepsy, Epilepsy, Partial, Epilepsy, Tonic-Clonic, Heart Failure, Congestive and Microalbuminuria, Hepatitis C, Chronic, Infection, Human Immunodeficiency Virus, Neoplasms, Prostate, Purpura, Thrombocytopaenic, Idiopathic

Studies at this site

• Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease — Completed
• LENS - Long-term Eltrombopag Observational Study — Completed
• COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria — Stopped early
• Pediatric Epilepsy Study in Subjects 1-24 Months — Completed
• A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen — Completed
• Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy — Completed
• Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures — Completed
• Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
• Advair Pediatric Once-Daily — Completed
• GSK BHR Study (Sont - Second Study) — Completed
• A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE) — Completed
• Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease — Completed
• Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease — Completed